60 Degrees Pharmaceuticals SXTP
NASDAQ SXTP
$0.86 -0.03 (-2.94%)
As of: Oct 22, 2026 · 12:03 PM EDT

60 Degrees Pharmaceuticals (SXTP) Total Debt (2022 - 2025)

Updated

60 Degrees Pharmaceuticals' Total Debt was $152,775 in Q4 2025, down 2.0% from $155,891 a year earlier.

Analysis

60 Degrees Pharmaceuticals (SXTP) Total Debt (2022 - 2025) Analysis & Trends

From Q4 2022 onward, 60 Degrees Pharmaceuticals has reported Total Debt for 6 quarters.

  • Total Debt shows a three-year compound annual growth rate of -81.0% (FY2022 to FY2025).
  • In earlier years, Total Debt was $155,891 in FY2024, $13,650 in FY2023 (-99.9%) and $22.24 million in FY2022.
  • The Q4 2025 figure marks the lowest quarterly Total Debt since Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,166.82 Bn 1,135.41 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 644.52 Bn 564.38 Bn 17.30 Bn 44.65 Bn
3 AbbVie 501.88 Bn 474.99 Bn 12.70 Bn 70.82 Bn
4 Merck 358.72 Bn 313.10 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 302.27 Bn 266.26 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 267.62 Bn 241.31 Bn 12.86 Bn 32.35 Bn
7 Amgen 241.67 Bn 197.07 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 193.09 Bn 167.28 Bn 6.22 Bn 26.25 Bn
9 Pfizer 171.60 Bn 118.24 Bn 10.94 Bn 63.19 Bn
10 60 Degrees Pharmaceuticals 2.29 Mn 1.27 Mn 56,798.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 152,775.00
Dec 31, 2024 155,891.00
Mar 31, 2024 8,772.00
Dec 31, 2023 22,422.00
Sep 30, 2023 2.17 Mn
Jun 30, 2023 51.85 Mn
Dec 31, 2022 22.24 Mn
API Access

60 Degrees Pharmaceuticals Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=SXTP&period=max&api_key=YOUR_API_KEY